Perhaps the FTO related indication approval could be met if BTD status is achieved using CPACS if the lead in bisantrene dose is shown to have an effect on FTO/m6a levels and is a necessary component of CPACS treatment? One for the lawyers I suppose. Hope the penalties aren't too severe at least.
CoH's legal team must have thought all their xmas's had come at once when Dr C and DCB sat down across from them.
Perhaps the FTO related indication approval could be met if BTD...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.045(3.15%) |
Mkt cap ! $241.9M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.44 | $1.38 | $42.40K | 30.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2109 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 935 | 2 |
View Market Depth
| Last trade - 11.21am 08/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |